← All companies
Gate Bioscience
Series B · $65M · Nov 2025 · 24 open roles
Biotechnology company developing a new class of small molecule medicines aiming to eliminate disease-causing proteins at their source
Get new roles in your inbox
Startups that just raised and are hiring. Plus an AI job concierge that emails you when a role fits what you’re after. Free.